SEC reporting owner

BAY CITY CAPITAL LLC SEC insider disclosures

Explore BAY CITY CAPITAL LLC's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001288452
Issuers
13
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

PONIARD PHARMACEUTICALS, INC.0000755806NERX, PARDNoNo
VIA Pharmaceuticals, Inc.0001003929VIAPNoNo
EnteroMedics Inc0001371217ETRMNoNo
SUNESIS PHARMACEUTICALS INC0001061027SNSSNoNo
HYPERION THERAPEUTICS INC0001386858HPTXNoNo
INTERLEUKIN GENETICS INC0001037649ILIUNoNo
Epizyme, Inc.0001571498EPZMNoNo
Dermira, Inc.0001557883DERMNoYes
NEVRO CORP0001444380NVRONoNo
MADRIGAL PHARMACEUTICALS, INC.0001157601MDGLNoYes
Kezar Life Sciences, Inc.0001645666KZRNoNo
IMARA Inc.0001672619IMRANoNo
Xilio Therapeutics, Inc.0001840233XLONoNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.